Agoston G. Szabo

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Identifying High-Risk Smoldering Multiple Myeloma for Early Intervention.

Identifying High-Risk Smoldering Multiple Myeloma for Early Intervention.

Journal: JAMA oncology

Published: April 23, 2026

Prediagnostic opioid use and survival in multiple myeloma: a nationwide register-based study.

Prediagnostic opioid use and survival in multiple myeloma: a nationwide register-based study.

Journal: Scientific reports

Published: March 12, 2026

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.

Journal: American journal of hematology

Published: March 09, 2026

Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group.

Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group.

Journal: British journal of haematology

Published: March 19, 2025

Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.

Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.

Journal: Haematologica

Published: January 31, 2025

Unexpected absence of fetal hemoglobin induction by lenalidomide in a patient with sickle cell anemia with concurrent multiple myeloma.

Unexpected absence of fetal hemoglobin induction by lenalidomide in a patient with sickle cell anemia with concurrent multiple myeloma.

Journal: Orphanet journal of rare diseases

Published: January 31, 2025

A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma.

A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma.

Journal: Blood cancer journal

Published: January 10, 2025

Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma.

Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma.

Journal: Leukemia

Published: December 05, 2023

Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.

Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.

Journal: EJHaem

Published: November 27, 2023

The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.

The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.

Journal: EJHaem

Published: July 13, 2023

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.

Journal: American journal of hematology

Published: September 10, 2021

Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.

Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.

Journal: Hematological oncology

Published: June 11, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026